Form D · Other
True Botanicals, Inc.
San Francisco, CA · CIK 0001735291
Offering snapshot reported Jul 28, 2020 · SEC filing
- Reported sold
- $4.52M Offering amount: $4.52M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Jul 15, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 28, 2020 | Initial | $4,520,753 | No comparison | 8 | SEC filing |
| Mar 27, 2018 | Initial | $14,073,532 | No comparison | 29 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-371904
Source: Form D, filed Jul 28, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Meghan Higney | Executive |
| Timothy Koogle | Director |
| Mats Lederhausen | Director |
| Christina Mace Turner | Director, Executive, Promoter |
| Brian Nicholson | Director |
| Anna Ohlsson Baskerville | Director |
| Hillary Peterson | Director, Promoter |
| Sandra Saputo | Director, Executive |
| Jon Sebastiani | Director |
Issuer details
Industry: Other (See others in industry)
Address:
522 Washington Street
San Francisco, CA, 94111
San Francisco, CA, 94111